Retraction: Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure (PLoS ONE (2013) 8: 3 (e58738) DOI: 10.1371/journal.pone.0058738);Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Xu, Xiao ^a   Liu, Xiaoli ^b   Ling, Qi ^a   Wei, Qiang ^a   Liu, Zhikun ^a   Xu, Xiaowei ^b   Zhou, Lin ^a   Zhang, Min ^a   Wu, Jian ^a   Huang, Jianrong ^b   Sheng, Jifang ^b   Zheng, Shusen ^a   Li, Lanjuan ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EMERGENCY SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER SUPPORT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875047665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0221917     Document Type: Erratum

References (26)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. (2009) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3: 269-282.
2. Santoro A, Mancini E, Buttiglieri S, Krause A, Yakubovich M, et al. (2004) Extracorporeal support of liver function (II Part). Int J Artif Organs 27: 176-185.
3. Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, et al. (2006) Artificial liver support system in China: a review over the last 30 years. Ther Apher Dial 10: 160-167.
4. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91-96.
5. Lu AW, Zheng SS, Wu MP, Shen Y, Yang RW, (2008) Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int 7: 357-361.
6. Xu X, Ling Q, He ZL, Gao F, Zheng SS, (2008) Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int 7: 465-470.
7. Adam R, Hoti E, (2009) Liver transplantation: the current situation. Semin Liver Dis 29: 3-18.
8. Matsui Y, Sugawara Y, Yamashiki N, Kaneko J, Tamura S, et al. (2008) Living donor liver transplantation for fulminant hepatic failure. Hepatol Res 38: 987-96.
9. Wu J, Zheng SS, (2004) Liver transplantation in China: problems and their solutions. Hepatobiliary Pancreat Dis Int 3: 170-174.
10. Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, et al. (2004) Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl 10: 1331-42.
11. Borra M, Galavotti D, Bellini C, Fumi L, Morsiani E, et al. (2002) Advanced technology for extracorporeal liver support system devices. Int J Artif Organs 25: 939-949.
12. Palmes D, Qayumi AK, Spiegel HU, (2000) Liver bridging techniques in the treatment of acute liver failure. J Invest Surg 13: 299-311.
13. Ichida T, (2003) Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation. Intern Med 42: 920-921.
14. Ueda Y, Iwata H, Paek HJ, Ko IK, Shimooka Y, et al. (2003) Bioartificial liver with whole blood perfusion. ASAIO J 49: 401-406.
15. Faenza S, Mancini E, Petrini F, Santoro A, Zanoni A, et al. (2004) Role of intensive therapy in liver transplant recipients: experience in blood purification and biosynthetic techniques. Transplant Proc 36: 555-575.
16. Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, et al. (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239: 660-667.
17. Nitta M, Hirasawa H, Oda S, Shiga H, Nakanishi K, et al. (2002) Long-term survivors with artificial liver support in fulminant hepatic failure. Ther Apher 6: 208-211.
18. Patzer II JF, Lopez RC, Zhu Y, Wang ZF, Mazariegos GV, et al. (2002) Bioartificial liver assist devices in support of patients with liver failure. Hepatobiliary Pancreat Dis Int 1: 18-25.
19. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C, (2003) Artificial and bioartificial support for acute and acute-on-chronic liver failure: a systematic review. JAMA 289: 217-222.
20. De Silvestro G, Marson P, Brandolese R, Pittoni G, Ongaro G, (2000) A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs 23: 454-461.
21. Sechser A, Osorio J, Freise C, Osorio RW, (2001) Artificial liver support devices for fulminant liver failure. Clin Liver Dis 5: 415-430.
22. Kozaki K, Fukatsu A, Kasahara M, Ogura Y, Egawa H, et al. (2004) The role of apheresis therapy in living donor liver transplantation. Ther Apher Dial 8: 174-179.
23. Felldin M, Friman S, Backman L, Siewert-Delle A, Henriksson BA, et al. (2003) Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transplant Proc 2003 35: 822-823.
24. Pascher A, Sauer IM, Hammer C, Gerlach JC, Neuhaus P, (2002) Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience. Xenotransplantation 9: 309-324.
25. Chamuleau RA, (2003) Artificial liver support in the third millennium. Artif Cells Blood Substit Immobil Biotechnol 31: 117-126.
26. Onodera K, Sakata H, Yonekawa M, Kawamura A, (2006) Artificial liver support at present and in the future. J Artif Organs 9: 17-28.